Also trades as: BIOG-B.ST (STO) · $vol 2M

$12.45

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 56 · $1.3B mcap · 84M float · 0.0000% daily turnover · Short 90% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$1.5B +8.1% ▲

5Y CAGR: +15.5%

Gross Profit

$1.1B +9.5% ▲

5Y CAGR: +15.6%

Operating Income

$412M -2.6% ▼

5Y CAGR: +12.6%

Net Income

$333M -5.3% ▼

5Y CAGR: +13.1%

EPS (Diluted)

$3.29 -5.5% ▼

5Y CAGR: +13.1%

EBITDA

$454M -15.8% ▼

5Y CAGR: +12.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$785M	$1.1B	$1.3B	$1.4B	$1.5B
YoY Growth	+5.1%	+40.6%	+17.4%	+9.7%	+8.1%
Cost of Revenue	$202M	$302M	$346M	$392M	$410M
Gross Profit	$583M	$802M	$950M	$1.0B	$1.1B
Gross Margin	74.3%	72.6%	73.3%	72.4%	73.4%
R&D Expenses	$105M	$107M	$107M	$157M	$116M
SG&A Expenses	$235M	$361M	$403M	$464M	$561M
Operating Expenses	$340M	$467M	$507M	$607M	$716M
Operating Income	$254M	$361M	$443M	$423M	$412M
Operating Margin	32.3%	32.7%	34.2%	29.8%	26.8%
Interest Expense	$1M	$5M	$809K	$15M	$8M
Income Before Tax	$253M	$448M	$469M	$448M	$421M
Tax Expense	$56M	$74M	$103M	$96M	$88M
Net Income	$196M	$374M	$365M	$351M	$333M
Net Margin	25.0%	33.9%	28.2%	24.7%	21.6%
EPS (Diluted)	$1.94	$3.70	$3.62	$3.48	$3.29
EBITDA	$277M	$477M	$455M	$539M	$454M
Shares Outstanding	101M	101M	101M	101M	101M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$304M	$365M	$366M	$405M	$322M	$441M	$373M	$441M
Cost of Revenue	$82M	$106M	$98M	$111M	$83M	$117M	$106M	$120M
Gross Profit	$222M	$259M	$268M	$294M	$239M	$324M	$267M	$321M
Gross Margin	73.1%	70.9%	73.3%	72.6%	74.2%	73.5%	71.6%	72.8%
R&D Expenses	$71M	$34M	$23M	$30M	$25M	$37M	$26M	$28M
SG&A Expenses	$105M	$134M	$124M	$150M	$125M	$160M	$146M	$167M
Operating Expenses	$181M	$155M	$171M	$186M	$150M	$203M	$166M	$189M
Operating Income	$41M	$103M	$97M	$108M	$89M	$121M	$101M	$132M
Operating Margin	13.6%	28.3%	26.5%	26.8%	27.5%	27.5%	27.2%	30.0%
Interest Expense	$2M	$10M	$2M	$3M	$4M	$230K	$2M	$62K
Income Before Tax	$47M	$104M	$102M	$110M	$84M	$124M	$102M	$134M
Tax Expense	$10M	$23M	$22M	$22M	$19M	$25M	$22M	$31M
Net Income	$37M	$82M	$80M	$88M	$65M	$99M	$79M	$103M
Net Margin	12.0%	22.5%	21.9%	21.7%	20.2%	22.4%	21.3%	23.4%
EPS (Diluted)	$0.36	$0.81	$0.79	$0.87	$0.64	$0.98	$0.78	$1.02
EBITDA	$107M	$121M	$110M	$119M	$94M	$130M	$110M	$140M
Shares Outstanding	101M	101M	101M	101M	101M	101M	101M	101M

BIOGY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet